BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 16288743)

  • 1. Topo II alpha reporter mice reveal proliferative regions in the epidermis and small intestine.
    Li ER; Watt FM
    FEBS Lett; 2005 Nov; 579(28):6479-85. PubMed ID: 16288743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin.
    Kishimoto J; Ehama R; Ge Y; Kobayashi T; Nishiyama T; Detmar M; Burgeson RE
    Am J Pathol; 2000 Jul; 157(1):103-10. PubMed ID: 10880381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage.
    Thougaard AV; Langer SW; Hainau B; Grauslund M; Juhl BR; Jensen PB; Sehested M
    Toxicology; 2010 Feb; 269(1):67-72. PubMed ID: 20079798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of topoisomerase II alpha and beta in HIV-1 infected and uninfected neuroblastoma and astrocytoma cells: involvement of distinct nordihydroguaretic acid sensitive inflammatory pathways.
    Mandraju RK; Kondapi AK
    Arch Biochem Biophys; 2007 May; 461(1):40-9. PubMed ID: 17391642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a thy1.2 GFP transgenic mouse reveals a tissue-specific organization of the spinal dorsal horn.
    Belle MD; Pattison EF; Cheunsuang O; Stewart A; Kramer I; Sigrist M; Arber S; Morris R
    Genesis; 2007 Nov; 45(11):679-88. PubMed ID: 17987661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hairless promoter is differentially regulated by thyroid hormone in keratinocytes and neuroblastoma cells.
    Engelhard A; Christiano AM
    Exp Dermatol; 2004 Apr; 13(4):257-64. PubMed ID: 15086342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proximal Gata4 promoter directs reporter gene expression to sertoli cells during mouse gonadal development.
    Mazaud Guittot S; Tétu A; Legault E; Pilon N; Silversides DW; Viger RS
    Biol Reprod; 2007 Jan; 76(1):85-95. PubMed ID: 17021344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated proliferation and abnormal differentiation of epidermal keratinocytes in endo-beta-galactosidase C transgenic mice.
    Misawa M; Watanabe S; Ihara S; Muramatsu T; Matsuzaki T
    Glycobiology; 2008 Jan; 18(1):20-7. PubMed ID: 17951373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of green fluorescent protein as a cell lineage marker.
    Swenson ES; Price JG; Brazelton T; Krause DS
    Stem Cells; 2007 Oct; 25(10):2593-600. PubMed ID: 17615263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased rate of hair regrowth in mice with constitutive overexpression of Del1.
    Hsu GP; Mathy JA; Wang Z; Xia W; Sakamoto G; Kundu R; Longaker MT; Quertermous T; Yang GP
    J Surg Res; 2008 May; 146(1):73-80. PubMed ID: 17764695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modification does not affect the stemness of neural stem cells in nestin promoter-GFP transgenic mice.
    Park JH; Ahn JI; Kim SY; Park KS; Lee YD; Yamaguchi M; Chung HJ
    Neurosci Lett; 2007 Jun; 421(3):185-90. PubMed ID: 17574339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.
    Day CP; Rau KM; Qiu L; Liu CW; Kuo HP; Xie X; Lopez-Berestein G; Hortobagyi GN; Hung MC
    Cancer Gene Ther; 2006 Jul; 13(7):706-19. PubMed ID: 16514421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miz1 is required for hair follicle structure and hair morphogenesis.
    Gebhardt A; Kosan C; Herkert B; Möröy T; Lutz W; Eilers M; Elsässer HP
    J Cell Sci; 2007 Aug; 120(Pt 15):2586-93. PubMed ID: 17635993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.
    Shvero J; Koren R; Shvili I; Yaniv E; Sadov R; Hadar T
    Am J Clin Pathol; 2008 Dec; 130(6):934-9. PubMed ID: 19019771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered connexin expression and wound healing in the epidermis of connexin-deficient mice.
    Kretz M; Euwens C; Hombach S; Eckardt D; Teubner B; Traub O; Willecke K; Ott T
    J Cell Sci; 2003 Aug; 116(Pt 16):3443-52. PubMed ID: 12840073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem/progenitor cell-specific enhanced green fluorescent protein expression driven by the endogenous Mcm2 promoter.
    Maslov AY; Bailey KJ; Mielnicki LM; Freeland AL; Sun X; Burhans WC; Pruitt SC
    Stem Cells; 2007 Jan; 25(1):132-8. PubMed ID: 17008428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of stem cells during prepubertal spermatogenesis via monitoring of nucleostemin promoter activity.
    Ohmura M; Naka K; Hoshii T; Muraguchi T; Shugo H; Tamase A; Uema N; Ooshio T; Arai F; Takubo K; Nagamatsu G; Hamaguchi I; Takagi M; Ishihara M; Sakurada K; Miyaji H; Suda T; Hirao A
    Stem Cells; 2008 Dec; 26(12):3237-46. PubMed ID: 18802033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
    Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
    Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.
    Segawa E; Sakurai K; Kishimoto H; Takaoka K; Noguchi K; Hashitani S; Hirota S; Urade M
    Oral Oncol; 2008 Jul; 44(7):664-71. PubMed ID: 17996482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.